跳至主要内容
临床试验/TCTR20221121005
TCTR20221121005
已完成
1 期

A study of microfocused ultrasound for the prevention of melasma in Asians: a single-blinded, randomized, split-face study

Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University0 个研究点目标入组 25 人2022年11月21日

概览

阶段
1 期
干预措施
未指定
疾病 / 适应症
Mixed type of melasma symmetrically distribute on both cheeks
发起方
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University
入组人数
25
状态
已完成
最后更新
去年

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2022年11月21日
结束日期
2022年3月31日
最后更新
去年
研究类型
Interventional
性别
All

研究者

发起方
Division of Dermatology, Department of Internal Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University

入排标准

入选标准

  • 1\. Mixed type of melasma on both cheeks
  • 2\. Can participate the follow up visit

排除标准

  • 1\. Having active infection on treatment area
  • 2\. Having open wound on treatment area
  • 3\. Having any of serious medical or dermatologic conditions including autoimmune disorders, scars, or severe cystic acne on the face, a history of skin cancer, a history of photosensitive disorders, or allergy to topical anesthesia
  • 4\. Having a previous history of taking oral contraceptive pills or hormone replacement within 1 year
  • 5\. Having a previous history of the following treatments or procedure for melasma including topical whitening agents within 1 month, oral or injected treatment within 3 months, laser treatment , dermabrasion, peeling, radiofrequency or focused ultrasound within 6 months
  • 6\. Having a history of filler injection on treatment area within 1 year
  • 7\. Having a previous history of metal implant on treatment area
  • 8\. Pregnancy or lactation
  • 9\. Withdraw from study

结局指标

主要结局

未指定

相似试验